ClearNote Health

Develops epigenomic liquid biopsy tests for early cancer detection.

BiotechnologyDiagnostics clearnotehealth.com ↗

Company facts

Founded
2016
Employees
50
Headquarters
United States
Type
Private
Funding
Series C · $21.8M · 2025